Pamela J. Mcdowell
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Lessons learned regarding optimal use of biologics to achieve disease remission in severe asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 15, 2026
Lessons learned regarding optimal use of biologics to achieve disease remission in severe asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 15, 2026
Persistent long-term HPA-axis Suppression after Maintenance Oral Corticosteroid Withdrawal in Severe Asthma: Biochemical Assessment is Essential.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 30, 2025
Persistent Long-Term Hypothalamic-Pituitary-Adrenal-Axis Suppression After Maintenance Oral Corticosteroid Withdrawal in Severe Asthma: Biochemical Assessment Is Essential.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 30, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma Registry.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 01, 2025
Investigating the Association Between Biologic Initiation and Medication Adherence in Severe Asthma: An Analysis of Linked Data.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 17, 2025
Disease Trajectory and Treatment Escalation in Asthma: A Retrospective Analysis of Data From the Optimum Patient Care Research Database (OPCRD).
Journal: The journal of allergy and clinical immunology. In practice
Published: April 01, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2024
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma.
Journal: ERJ open research
Published: October 21, 2024
Corrigendum to "The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time" [Seminars in Arthritis and Rheumatism 55 (2022):152010].
Journal: Seminars in arthritis and rheumatism
Published: July 02, 2024
Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis.
Journal: The Lancet. Respiratory medicine
Published: May 01, 2024
Last Updated: 09/26/2026